Advertisement

Index by author

July 01, 1991; Volume 258,Issue 1

A

  1. Abdelhamid, E E

    1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
      E E Abdelhamid, M Sultana, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 299-303;

  2. Abel, P W

    1. Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney.
      F Feng, W A Pettinger, P W Abel and W B Jeffries
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 263-268;

  3. Abildgaard, U

    1. Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
      J S Petersen, M Shalmi, U Abildgaard and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 42-48;

  4. Adeagbo, A S

    1. Mechanism of vascular smooth muscle contraction by sodium fluoride in the isolated aorta of rat and rabbit.
      A S Adeagbo and C R Triggle
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 66-73;

  5. Aharony, D

    1. Evidence for leukotriene D4 receptors in guinea pig left atria.
      R C Falcone, D Aharony and R F Orzechowski
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 199-206;

  6. Allgaier, C

    1. A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus.
      C Allgaier, G Hertting and E A Singer
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 143-148;

  7. Andén, N E

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  8. Antoine, M H

    1. Ionic and secretory response of pancreatic islet cells to minoxidil sulfate.
      M H Antoine, M Hermann, A Herchuelz and P Lebrun
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 286-291;

  9. Atchison, W D

    1. Methylmercury blocks N- and L-type Ca++ channels in nerve growth factor-differentiated pheochromocytoma (PC12) cells.
      T J Shafer and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 149-157;

  10. Au, J L

    1. Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
      J L Au, J T Dalton and M G Wientjes
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 357-364;

B

  1. Baldwin, H

    1. Anxiolytic activity of steroid anesthetic alphaxalone.
      K T Britton, M Page, H Baldwin and G F Koob
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 124-129;

  2. Barnes, P J

    1. Bombesin-induced bronchoconstriction in the guinea pig: mode of action.
      M G Belvisi, C D Stretton and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 36-41;

  3. Bejanian, M

    1. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
      M Bejanian, R N Pechnick, M P Bova and R George
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 88-93;

  4. Belvisi, M G

    1. Bombesin-induced bronchoconstriction in the guinea pig: mode of action.
      M G Belvisi, C D Stretton and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 36-41;

  5. Bertaccini, G

    1. Histamine receptors in isolated guinea pig duodenal muscle: H3 receptors inhibit cholinergic neurotransmission.
      G Coruzzi, E Poli and G Bertaccini
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 325-331;

  6. Björk, L

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  7. Blaine, E H

    1. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor.
      A J Trapani, G J Smits, D E McGraw, E G McMahon and E H Blaine
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 269-274;

  8. Boublik, J H

    1. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.
      X Y Hua, J H Boublik, M A Spicer, J E Rivier, M R Brown and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 243-248;

  9. Bova, M P

    1. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
      M Bejanian, R N Pechnick, M P Bova and R George
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 88-93;

  10. Breuiller-Fouche, M

    1. Alpha-1 adrenergic receptor: binding and phosphoinositide breakdown in human myometrium.
      M Breuiller-Fouche, F Doualla-Bell Kotto Maka, B Geny and F Ferre
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 82-87;

  11. Britton, K T

    1. Anxiolytic activity of steroid anesthetic alphaxalone.
      K T Britton, M Page, H Baldwin and G F Koob
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 124-129;

  12. Brown, M R

    1. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.
      X Y Hua, J H Boublik, M A Spicer, J E Rivier, M R Brown and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 243-248;

  13. Bucher, K D

    1. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
      D W Hein, T D Rustan, K D Bucher, E J Furman and W J Martin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 232-236;

  14. Buciak, J L

    1. Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate.
      D Triguero, J L Buciak and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 186-192;

  15. Byrd, L D

    1. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.
      L L Howell and L D Byrd
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 178-185;

C

  1. Caudle, R M

    1. Endogenous opioids released from perforant path modulate norepinephrine actions and inhibitory postsynaptic potentials in guinea pig CA3 pyramidal cells.
      R M Caudle, J J Wagner and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 18-26;

  2. Cavero, I

    1. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
      J Pratz, S Mondot, F Montier and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 216-222;

  3. Chavkin, C

    1. Endogenous opioids released from perforant path modulate norepinephrine actions and inhibitory postsynaptic potentials in guinea pig CA3 pyramidal cells.
      R M Caudle, J J Wagner and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 18-26;

  4. Chiba, S

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

  5. Chirtel, S J

    1. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on intermediary metabolism in the rat.
      M R Lakshman, P Ghosh and S J Chirtel
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 317-319;

  6. Christensen, S

    1. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.
      J S Petersen, M Shalmi, H R Lam and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 1-7;
    2. Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
      J S Petersen, M Shalmi, U Abildgaard and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 42-48;

  7. Coffin, V L

    1. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
      L C Iorio, M Cohen and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 118-123;

  8. Cohen, M

    1. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
      L C Iorio, M Cohen and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 118-123;

  9. Collier, B H

    1. Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats.
      S H Pollock, M I Reichbaum, B H Collier and M J D'Souza
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 8-12;

  10. Cornfield, L J

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  11. Coruzzi, G

    1. Histamine receptors in isolated guinea pig duodenal muscle: H3 receptors inhibit cholinergic neurotransmission.
      G Coruzzi, E Poli and G Bertaccini
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 325-331;

D

  1. D'Souza, M J

    1. Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats.
      S H Pollock, M I Reichbaum, B H Collier and M J D'Souza
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 8-12;

  2. Dalton, J T

    1. Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
      J L Au, J T Dalton and M G Wientjes
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 357-364;

  3. DiBona, G F

    1. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
      D R Kapusta, S Y Jones and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 111-117;

  4. Doualla-Bell Kotto Maka, F

    1. Alpha-1 adrenergic receptor: binding and phosphoinositide breakdown in human myometrium.
      M Breuiller-Fouche, F Doualla-Bell Kotto Maka, B Geny and F Ferre
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 82-87;

  5. Drijfhout, J W

    1. Endothelins: functional and autoradiographic studies in guinea pig trachea.
      E J Tschirhart, J W Drijfhout, J T Pelton, R C Miller and C R Jones
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 381-387;

  6. Duckles, S P

    1. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
      A L Garcia-Villalon, D N Krause, F J Ehlert and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 304-310;

  7. Duncan, M W

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

E

  1. Ehlert, F J

    1. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
      A L Garcia-Villalon, D N Krause, F J Ehlert and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 304-310;

  2. Elfarra, A A

    1. Kidney-selective prodrugs of 6-mercaptopurine: biochemical basis of the kidney selectivity of S-(6-purinyl)-L-cysteine and metabolism of new analogs in rats.
      I Y Hwang and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 171-177;

F

  1. Falcone, R C

    1. Evidence for leukotriene D4 receptors in guinea pig left atria.
      R C Falcone, D Aharony and R F Orzechowski
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 199-206;

  2. Fedan, J S

    1. Involvement of ecto-phosphoryl transfer in contractions of the smooth muscle of the guinea pig vas deferens to adenosine 5'-triphosphate.
      S J Lamport-Vrana, K E Vrana and J S Fedan
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 339-348;

  3. Feinberg, H

    1. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction.
      S L Lee, S Levitsky and H Feinberg
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 292-298;

  4. Feng, F

    1. Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney.
      F Feng, W A Pettinger, P W Abel and W B Jeffries
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 263-268;

  5. Ferre, F

    1. Alpha-1 adrenergic receptor: binding and phosphoinositide breakdown in human myometrium.
      M Breuiller-Fouche, F Doualla-Bell Kotto Maka, B Geny and F Ferre
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 82-87;

  6. Fitzgerald, D J

    1. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
      L Furci, D J Fitzgerald and G A Fitzgerald
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 74-81;

  7. Fitzgerald, G A

    1. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
      L Furci, D J Fitzgerald and G A Fitzgerald
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 74-81;

  8. Fleming, W W

    1. Mesenteric vascular responses of young spontaneously hypertensive rats.
      J Q Kong, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 13-17;

  9. Furci, L

    1. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
      L Furci, D J Fitzgerald and G A Fitzgerald
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 74-81;

  10. Furman, E J

    1. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
      D W Hein, T D Rustan, K D Bucher, E J Furman and W J Martin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 232-236;

  11. Furukawa, Y

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

G

  1. Galpern, W R

    1. Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142.
      G A Pritchard, W R Galpern, M Lumpkin and L G Miller
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 280-285;

  2. Garcia, J

    1. The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts.
      O Schmidlin, J Garcia and J B Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 130-135;

  3. Garcia-Villalon, A L

    1. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
      A L Garcia-Villalon, D N Krause, F J Ehlert and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 304-310;

  4. Geny, B

    1. Alpha-1 adrenergic receptor: binding and phosphoinositide breakdown in human myometrium.
      M Breuiller-Fouche, F Doualla-Bell Kotto Maka, B Geny and F Ferre
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 82-87;

  5. George, R

    1. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
      M Bejanian, R N Pechnick, M P Bova and R George
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 88-93;

  6. Ghosh, P

    1. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on intermediary metabolism in the rat.
      M R Lakshman, P Ghosh and S J Chirtel
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 317-319;

  7. Givens, B S

    1. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
      T C Napier, P E Simson and B S Givens
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 249-262;

  8. Grenader, A

    1. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
      A Grenader and D P Healy
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 193-198;

  9. Gullikson, G W

    1. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
      G W Gullikson, R F Loeffler and M A Viriña
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 103-110;

H

  1. Hacksell, U

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  2. Harrison, D G

    1. L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels.
      F W Sellke, R J Tomanek and D G Harrison
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 365-369;

  3. Hayashi, M

    1. Beneficial effects of yohimbine on posthypoxic recovery of cardiac function and myocardial metabolism in isolated perfused rabbit hearts.
      S Takeo, M Hayashi, K Tanonaka and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 94-102;

  4. Healy, D P

    1. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
      A Grenader and D P Healy
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 193-198;

  5. Hein, D W

    1. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
      D W Hein, T D Rustan, K D Bucher, E J Furman and W J Martin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 232-236;

  6. Herchuelz, A

    1. Ionic and secretory response of pancreatic islet cells to minoxidil sulfate.
      M H Antoine, M Hermann, A Herchuelz and P Lebrun
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 286-291;

  7. Hermann, M

    1. Ionic and secretory response of pancreatic islet cells to minoxidil sulfate.
      M H Antoine, M Hermann, A Herchuelz and P Lebrun
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 286-291;

  8. Hertting, G

    1. A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus.
      C Allgaier, G Hertting and E A Singer
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 143-148;

  9. Hillver, S E

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  10. Hogenboom, F

    1. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
      A N Schoffelmeer, G Warden, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 237-242;

  11. Howell, L L

    1. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.
      L L Howell and L D Byrd
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 178-185;

  12. Hua, X Y

    1. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.
      X Y Hua, J H Boublik, M A Spicer, J E Rivier, M R Brown and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 243-248;

  13. Hwang, I Y

    1. Kidney-selective prodrugs of 6-mercaptopurine: biochemical basis of the kidney selectivity of S-(6-purinyl)-L-cysteine and metabolism of new analogs in rats.
      I Y Hwang and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 171-177;

I

  1. Iorio, L C

    1. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
      L C Iorio, M Cohen and V L Coffin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 118-123;

  2. Ito, H

    1. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

  3. Ito, M

    1. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

J

  1. Jeffries, W B

    1. Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney.
      F Feng, W A Pettinger, P W Abel and W B Jeffries
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 263-268;

  2. Jones, C R

    1. Endothelins: functional and autoradiographic studies in guinea pig trachea.
      E J Tschirhart, J W Drijfhout, J T Pelton, R C Miller and C R Jones
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 381-387;

  3. Jones, S Y

    1. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
      D R Kapusta, S Y Jones and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 111-117;

K

  1. Kapusta, D R

    1. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
      D R Kapusta, S Y Jones and G F DiBona
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 111-117;

  2. Karasawa, Y

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

  3. Keeton, T K

    1. Captopril increases norepinephrine spillover rate in conscious spontaneously hypertensive rats.
      Y J Kuo and T K Keeton
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 223-231;

  4. Knight, D L

    1. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
      M J Owens, M A Vargas, D L Knight and C B Nemeroff
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 349-356;

  5. Kodama, I

    1. Effects of KT-362, a new antiarrhythmic agent with vasodilating action on intracellular calcium mobilization of atrial muscle.
      I Kodama and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 332-338;

  6. Kong, J Q

    1. Mesenteric vascular responses of young spontaneously hypertensive rats.
      J Q Kong, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 13-17;

  7. Koob, G F

    1. Anxiolytic activity of steroid anesthetic alphaxalone.
      K T Britton, M Page, H Baldwin and G F Koob
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 124-129;

  8. Kopin, I J

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

  9. Krause, D N

    1. Heterogeneity of muscarinic receptor subtypes in cerebral blood vessels.
      A L Garcia-Villalon, D N Krause, F J Ehlert and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 304-310;

  10. Kuo, Y J

    1. Captopril increases norepinephrine spillover rate in conscious spontaneously hypertensive rats.
      Y J Kuo and T K Keeton
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 223-231;

L

  1. Lakshman, M R

    1. Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin on intermediary metabolism in the rat.
      M R Lakshman, P Ghosh and S J Chirtel
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 317-319;

  2. Lam, H R

    1. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.
      J S Petersen, M Shalmi, H R Lam and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 1-7;

  3. Lamport-Vrana, S J

    1. Involvement of ecto-phosphoryl transfer in contractions of the smooth muscle of the guinea pig vas deferens to adenosine 5'-triphosphate.
      S J Lamport-Vrana, K E Vrana and J S Fedan
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 339-348;

  4. Lebrun, P

    1. Ionic and secretory response of pancreatic islet cells to minoxidil sulfate.
      M H Antoine, M Hermann, A Herchuelz and P Lebrun
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 286-291;

  5. Lee, S L

    1. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction.
      S L Lee, S Levitsky and H Feinberg
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 292-298;

  6. Levitsky, S

    1. Endogenous vasoconstrictor prostanoids: role in serotonin and vasopressin-induced coronary vasoconstriction.
      S L Lee, S Levitsky and H Feinberg
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 292-298;

  7. Lewander, T

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  8. Loeffler, R F

    1. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
      G W Gullikson, R F Loeffler and M A Viriña
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 103-110;

  9. Lumpkin, M

    1. Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142.
      G A Pritchard, W R Galpern, M Lumpkin and L G Miller
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 280-285;

M

  1. Markey, S P

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

  2. Martin, W J

    1. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
      D W Hein, T D Rustan, K D Bucher, E J Furman and W J Martin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 232-236;

  3. McCallum, R W

    1. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
      R W McCallum, G Valenzuela, S Polepalle and D Spyker
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 136-142;

  4. McGraw, D E

    1. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor.
      A J Trapani, G J Smits, D E McGraw, E G McMahon and E H Blaine
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 269-274;

  5. McMahon, E G

    1. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor.
      A J Trapani, G J Smits, D E McGraw, E G McMahon and E H Blaine
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 269-274;

  6. Miller, L G

    1. Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142.
      G A Pritchard, W R Galpern, M Lumpkin and L G Miller
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 280-285;

  7. Miller, R C

    1. Endothelins: functional and autoradiographic studies in guinea pig trachea.
      E J Tschirhart, J W Drijfhout, J T Pelton, R C Miller and C R Jones
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 381-387;

  8. Mondot, S

    1. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
      J Pratz, S Mondot, F Montier and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 216-222;

  9. Monteiro, J G

    1. A kinetic study of the ouabain-induced efflux of norepinephrine from the dog saphenous vein.
      J G Monteiro
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 311-316;

  10. Montier, F

    1. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
      J Pratz, S Mondot, F Montier and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 216-222;

  11. Mulder, A H

    1. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
      A N Schoffelmeer, G Warden, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 237-242;

  12. Murakami, M

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

N

  1. Nance, D

    1. Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.
      J Sawynok, A Reid and D Nance
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 370-380;

  2. Napier, T C

    1. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
      T C Napier, P E Simson and B S Givens
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 249-262;

  3. Narita, M

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

  4. Naruse, A

    1. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

  5. Nelson, D L

    1. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
      L Björk, L J Cornfield, D L Nelson, S E Hillver, N E Andén, T Lewander and U Hacksell
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 58-65;

  6. Nemeroff, C B

    1. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
      M J Owens, M A Vargas, D L Knight and C B Nemeroff
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 349-356;

O

  1. Oguri, M

    1. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

  2. Okamura, T

    1. Responses to dopamine of isolated human and monkey veins compared with those of the arteries.
      T Okamura, M Yamazaki and N Toda
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 275-279;

  3. Orzechowski, R F

    1. Evidence for leukotriene D4 receptors in guinea pig left atria.
      R C Falcone, D Aharony and R F Orzechowski
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 199-206;

  4. Owens, M J

    1. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
      M J Owens, M A Vargas, D L Knight and C B Nemeroff
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 349-356;

  5. Owens, S M

    1. Phencyclidine dependence: the relationship of dose and serum concentrations to operant behavioral effects.
      W D Wessinger and S M Owens
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 207-215;

P

  1. Page, M

    1. Anxiolytic activity of steroid anesthetic alphaxalone.
      K T Britton, M Page, H Baldwin and G F Koob
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 124-129;

  2. Pardridge, W M

    1. Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate.
      D Triguero, J L Buciak and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 186-192;

  3. Pearson, P G

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

  4. Pechnick, R N

    1. Effects of subcutaneous and intracerebroventricular administration of the sigma receptor ligand 1,3-Di-o-tolylguanidine on body temperature in the rat: interactions with BMY 14802 and rimcazole.
      M Bejanian, R N Pechnick, M P Bova and R George
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 88-93;

  5. Pelton, J T

    1. Endothelins: functional and autoradiographic studies in guinea pig trachea.
      E J Tschirhart, J W Drijfhout, J T Pelton, R C Miller and C R Jones
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 381-387;

  6. Petersen, J S

    1. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.
      J S Petersen, M Shalmi, H R Lam and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 1-7;
    2. Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
      J S Petersen, M Shalmi, U Abildgaard and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 42-48;

  7. Pettinger, W A

    1. Regional distribution of alpha 1-adrenoceptor subtypes in rat kidney.
      F Feng, W A Pettinger, P W Abel and W B Jeffries
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 263-268;

  8. Piascik, M T

    1. Interaction of imidazolines with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes.
      M T Piascik, M S Sparks and T A Pruitt
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 158-165;

  9. Polepalle, S

    1. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
      R W McCallum, G Valenzuela, S Polepalle and D Spyker
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 136-142;

  10. Poli, E

    1. Histamine receptors in isolated guinea pig duodenal muscle: H3 receptors inhibit cholinergic neurotransmission.
      G Coruzzi, E Poli and G Bertaccini
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 325-331;

  11. Pollock, S H

    1. Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats.
      S H Pollock, M I Reichbaum, B H Collier and M J D'Souza
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 8-12;

  12. Portoghese, P S

    1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
      E E Abdelhamid, M Sultana, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 299-303;

  13. Pratz, J

    1. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats.
      J Pratz, S Mondot, F Montier and I Cavero
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 216-222;

  14. Pritchard, G A

    1. Chronic benzodiazepine administration. VIII. Receptor upregulation produced by chronic exposure to the inverse agonist FG-7142.
      G A Pritchard, W R Galpern, M Lumpkin and L G Miller
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 280-285;

  15. Pruitt, T A

    1. Interaction of imidazolines with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes.
      M T Piascik, M S Sparks and T A Pruitt
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 158-165;

R

  1. Rapoport, S I

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

  2. Reichbaum, M I

    1. Inhibitory effect of cyclosporine A on the activity of oral hypoglycemic agents in rats.
      S H Pollock, M I Reichbaum, B H Collier and M J D'Souza
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 8-12;

  3. Reid, A

    1. Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.
      J Sawynok, A Reid and D Nance
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 370-380;

  4. Ren, L M

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

  5. Rivier, J E

    1. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.
      X Y Hua, J H Boublik, M A Spicer, J E Rivier, M R Brown and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 243-248;

  6. Rustan, T D

    1. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model.
      D W Hein, T D Rustan, K D Bucher, E J Furman and W J Martin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 232-236;

S

  1. Satake, N

    1. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

  2. Sawynok, J

    1. Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.
      J Sawynok, A Reid and D Nance
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 370-380;

  3. Schmidlin, O

    1. The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts.
      O Schmidlin, J Garcia and J B Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 130-135;

  4. Schoffelmeer, A N

    1. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
      A N Schoffelmeer, G Warden, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 237-242;

  5. Schwartz, J B

    1. The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts.
      O Schmidlin, J Garcia and J B Schwartz
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 130-135;

  6. Sellke, F W

    1. L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels.
      F W Sellke, R J Tomanek and D G Harrison
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 365-369;

  7. Shafer, T J

    1. Methylmercury blocks N- and L-type Ca++ channels in nerve growth factor-differentiated pheochromocytoma (PC12) cells.
      T J Shafer and W D Atchison
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 149-157;

  8. Shalmi, M

    1. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.
      J S Petersen, M Shalmi, H R Lam and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 1-7;
    2. Alpha-1 blockade inhibits compensatory sodium reabsorption in the proximal tubules during furosemide-induced volume contraction.
      J S Petersen, M Shalmi, U Abildgaard and S Christensen
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 42-48;

  9. Shibata, S

    1. Effects of KT-362, a new antiarrhythmic agent with vasodilating action on intracellular calcium mobilization of atrial muscle.
      I Kodama and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 332-338;
    2. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

  10. Simson, P E

    1. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
      T C Napier, P E Simson and B S Givens
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 249-262;

  11. Singer, E A

    1. A detailed study on the effects of protein kinase C activation on alpha-2 adrenoceptor-coupled modulation of norepinephrine release in hippocampus.
      C Allgaier, G Hertting and E A Singer
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 143-148;

  12. Sitar, D S

    1. Differential effects of histamine H2 receptor antagonists on amantadine uptake in the rat renal cortical slice, isolated proximal tubule and distal tubule.
      L T Wong, D D Smyth and D S Sitar
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 320-324;

  13. Smith, Q R

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

  14. Smits, G J

    1. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor.
      A J Trapani, G J Smits, D E McGraw, E G McMahon and E H Blaine
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 269-274;

  15. Smyth, D D

    1. Differential effects of histamine H2 receptor antagonists on amantadine uptake in the rat renal cortical slice, isolated proximal tubule and distal tubule.
      L T Wong, D D Smyth and D S Sitar
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 320-324;

  16. Sparks, M S

    1. Interaction of imidazolines with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes.
      M T Piascik, M S Sparks and T A Pruitt
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 158-165;

  17. Spicer, M A

    1. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.
      X Y Hua, J H Boublik, M A Spicer, J E Rivier, M R Brown and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 243-248;

  18. Spyker, D

    1. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
      R W McCallum, G Valenzuela, S Polepalle and D Spyker
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 136-142;

  19. Stretton, C D

    1. Bombesin-induced bronchoconstriction in the guinea pig: mode of action.
      M G Belvisi, C D Stretton and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 36-41;

  20. Sultana, M

    1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
      E E Abdelhamid, M Sultana, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 299-303;

  21. Suzuki, Y

    1. Impaired endothelium-dependent relaxation in isolated thoracic aorta of rats with daunomycin-induced nephrosis.
      M Ito, M Oguri, A Naruse, H Ito, Y Suzuki, N Satake and S Shibata
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 388-395;

T

  1. Takei, M

    1. Functional participation in M1 receptor subtype on chronotropic and dromotropic responses to vagus stimulation in anesthetized dogs.
      M Narita, Y Furukawa, M Takei, M Murakami, L M Ren, Y Karasawa and S Chiba
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 166-170;

  2. Takemori, A E

    1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
      E E Abdelhamid, M Sultana, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 299-303;

  3. Takeo, S

    1. Beneficial effects of yohimbine on posthypoxic recovery of cardiac function and myocardial metabolism in isolated perfused rabbit hearts.
      S Takeo, M Hayashi, K Tanonaka and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 94-102;

  4. Tanonaka, K

    1. Beneficial effects of yohimbine on posthypoxic recovery of cardiac function and myocardial metabolism in isolated perfused rabbit hearts.
      S Takeo, M Hayashi, K Tanonaka and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 94-102;

  5. Taylor, D A

    1. Mesenteric vascular responses of young spontaneously hypertensive rats.
      J Q Kong, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 13-17;

  6. Timmermans, P B

    1. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
      P C Wong and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 49-57;

  7. Toda, N

    1. Responses to dopamine of isolated human and monkey veins compared with those of the arteries.
      T Okamura, M Yamazaki and N Toda
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 275-279;

  8. Tomanek, R J

    1. L-cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels.
      F W Sellke, R J Tomanek and D G Harrison
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 365-369;

  9. Trapani, A J

    1. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor.
      A J Trapani, G J Smits, D E McGraw, E G McMahon and E H Blaine
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 269-274;

  10. Triggle, C R

    1. Mechanism of vascular smooth muscle contraction by sodium fluoride in the isolated aorta of rat and rabbit.
      A S Adeagbo and C R Triggle
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 66-73;

  11. Triguero, D

    1. Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate.
      D Triguero, J L Buciak and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 186-192;

  12. Tschirhart, E J

    1. Endothelins: functional and autoradiographic studies in guinea pig trachea.
      E J Tschirhart, J W Drijfhout, J T Pelton, R C Miller and C R Jones
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 381-387;

V

  1. Valenzuela, G

    1. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics.
      R W McCallum, G Valenzuela, S Polepalle and D Spyker
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 136-142;

  2. Vargas, M A

    1. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.
      M J Owens, M A Vargas, D L Knight and C B Nemeroff
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 349-356;

  3. Villacreses, N E

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

  4. Viriña, M A

    1. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
      G W Gullikson, R F Loeffler and M A Viriña
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 103-110;

  5. Vrana, K E

    1. Involvement of ecto-phosphoryl transfer in contractions of the smooth muscle of the guinea pig vas deferens to adenosine 5'-triphosphate.
      S J Lamport-Vrana, K E Vrana and J S Fedan
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 339-348;

W

  1. Wagner, J J

    1. Endogenous opioids released from perforant path modulate norepinephrine actions and inhibitory postsynaptic potentials in guinea pig CA3 pyramidal cells.
      R M Caudle, J J Wagner and C Chavkin
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 18-26;

  2. Warden, G

    1. Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.
      A N Schoffelmeer, G Warden, F Hogenboom and A H Mulder
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 237-242;

  3. Wessinger, W D

    1. Phencyclidine dependence: the relationship of dose and serum concentrations to operant behavioral effects.
      W D Wessinger and S M Owens
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 207-215;

  4. Wientjes, M G

    1. Evidence of significant absorption of sodium salicylate from urinary bladder of rats.
      J L Au, J T Dalton and M G Wientjes
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 357-364;

  5. Wong, L T

    1. Differential effects of histamine H2 receptor antagonists on amantadine uptake in the rat renal cortical slice, isolated proximal tubule and distal tubule.
      L T Wong, D D Smyth and D S Sitar
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 320-324;

  6. Wong, P C

    1. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
      P C Wong and P B Timmermans
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 49-57;

  7. Wyatt, L

    1. 2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat.
      M W Duncan, N E Villacreses, P G Pearson, L Wyatt, S I Rapoport, I J Kopin, S P Markey and Q R Smith
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 27-35;

Y

  1. Yaksh, T L

    1. The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship.
      X Y Hua, J H Boublik, M A Spicer, J E Rivier, M R Brown and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 243-248;

  2. Yamamoto, K

    1. Beneficial effects of yohimbine on posthypoxic recovery of cardiac function and myocardial metabolism in isolated perfused rabbit hearts.
      S Takeo, M Hayashi, K Tanonaka and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 94-102;

  3. Yamazaki, M

    1. Responses to dopamine of isolated human and monkey veins compared with those of the arteries.
      T Okamura, M Yamazaki and N Toda
      Journal of Pharmacology and Experimental Therapeutics July 1991, 258 (1) 275-279;
Back to top

In this issue